Pharmabiz6m
Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Novartis announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. Previous guidance for +5% sales CAGR 2023-2028 was ...
Pharmabiz1h
BioLineRx & Ayrmid ink exclusive license agreement to commercialize Aphexda through Gamida Cell
BioLineRx Ltd., a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Ayrmid Ltd. (Ayrmid), the parent company of Gamida Cell Ltd., announced ...
Pharmabiz2h
Study links rare genetic mutation to severe neurological disorder
Study links rare genetic mutation to severe neurological disorder: Krems, Austria Friday, November 22, 2024, 11:00 Hrs [IST] A recent study has uncovered the intricate ways in whi ...
Pharmabiz19h
Boehringer Ingelheim India and RED.Health ambulance services sign MoU to strengthen emergency stroke care in pre-hospital setup in India
Our Bureau, Mumbai Thursday, November 21, 2024, 17:30 Hrs [IST] ...
Pharmabiz3h
US FDA approves Jazz Pharma’s Ziihera to treat adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer
US FDA approves Jazz Pharma’s Ziihera to treat adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer: Dublin Friday, November 22, 2024, 1 ...
Pharmabiz4h
WHO grants Emergency Use Listing for LC16m8 mpox vaccine
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General’s ...
Pharmabiz5h
CDRI Lucknow to hold industry conclave-cum-panel discussions on Revised Schedule M on Nov 23
Peethaambaran Kunnathoor, Chennai Friday, November 22, 2024, 08:00 Hrs [IST] ...
Pharmabiz5h
ICMR invites proposals for clinical studies on medical device and diagnostic technologies under CAR scheme
ICMR invites proposals for clinical studies on medical device and diagnostic technologies under CAR scheme: Shardul Nautiyal, Mumbai Friday, November 22, 2024, 08:00 Hrs [IST] The ...
Pharmabiz5h
IISc partners with UCL to accelerate research in clinical sciences and quantum technology
IISc partners with UCL to accelerate research in clinical sciences and quantum technology: Nandita Vijayasimha, Bengaluru Friday, November 22, 2024, 08:00 Hrs [IST] The Indian Ins ...
Pharmabiz5h
Bioengineering is the new frontier in advanced technology: Kiran Mazumdar Shaw
Digital technologies have transformed biology research to provide in-depth insights into unravelling the mysteries of living systems. Bioengineering is the new frontier in advanced technology, said ...
Pharmabiz5h
Centre to amend MDR to detail timelines related to medical devices manufacturing license
Centre to amend MDR to detail timelines related to medical devices manufacturing license: Gireesh Babu, New Delhi Friday, November 22, 2024, 08:00 Hrs [IST] In order to better str ...
Pharmabiz18h
Abbott unveils new recommendations and partnerships to improve diversity in clinical trials
Abbott announced that, in the third year of its multi-million-dollar Diversity in Clinical Trials initiative, the company has published 'Advancing Diversity in Clinical Trials' to share strategies to ...